bioio
Founded 2019 · 4 employees on LinkedIn · 3 known investors
Find your way into bioio
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
Founders & leadership
bioio was founded in 2019 by Dr. Peterson.
DP
Dr. Peterson
Investors · 3
Competitors · 6
by search overlap
iBio15 shared keywordsiBio is a biopharmaceutical company with leadership experienced in drug discovery, development, and clinical operations across multiple therapeutic areas. The company appears to focus on innovative therapeutics and biologics development.
bio11 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Bridgebio7 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Percipio5 shared keywordsPercipio Health helps independent primary care practices claim Advanced Primary Care Management (APCM) reimbursements from Medicare that most practices do not yet operationalize. The company focuses on capturing unclaimed revenue for small independent primary care physician groups.
Indiebio5 shared keywordsIndieBio was a startup accelerator and pre-seed investment program launched by SOSV in San Francisco in 2015, providing on-site bio-labs and funding to science founders across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics. As of 2026 the program was rebranded to SOSV NY and SOSV SF, expanding its focus from bio to broader deep tech.
BodyBio5 shared keywordsBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
Companies competing with bioio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does bioio do?
- BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
- Who founded bioio?
- bioio was founded by Dr. Peterson in 2019.
- Who are bioio's investors?
- bioio's investors include BioGenerator Ventures, Missouri Technology Corporation, quadraScope Venture Fund.